Abstract
Strategies to treat Zika virus (ZIKV) infection in dengue virus (DENV)-endemic areas are urgently needed. Here we show that a DENV-specific antibody against the E-dimer epitope (EDE) potently cross-neutralizes ZIKV and provides robust therapeutic efficacy as well as prophylactic efficacy against ZIKV in rhesus monkeys. Viral escape was not detected, suggesting a relatively high bar to escape. These data demonstrate the potential for antibody-based therapy and prevention of ZIKV.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mlakar, J. et al. N. Engl. J. Med. 374, 951–958 (2016).
Brasil, P. et al. Lancet 387, 1482 (2016).
Abbink, P. et al. Science 353, 1129–1132 (2016).
Larocca, R. A. et al. Nature 536, 474–478 (2016).
Dowd, K. A. et al. Science 354, 237–240 (2016).
Pardi, N. et al. Nature 543, 248–251 (2017).
Aid, M. et al. Cell 169, 610–620.e614 (2017).
Fernandez, E. et al. Nat. Immunol. 18, 1261–1269 (2017).
Wang, J. et al. Cell 171, 229–241.e215 (2017).
Kam, Y. W. et al. JCI Insight 2, 92428 (2017).
Sapparapu, G. et al. Nature 540, 443–447 (2016).
Magnani, D. M. et al. Sci. Transl. Med. 9, eaan8184 (2017).
Stettler, K. et al. Science 353, 823–826 (2016).
Bardina, S. V. et al. Science 356, 175–180 (2017).
Dejnirattisai, W. et al. Nat. Immunol. 17, 1102–1108 (2016).
Barba-Spaeth, G. et al. Nature 536, 48–53 (2016).
Dejnirattisai, W. et al. Nat. Immunol. 16, 170–177 (2015).
Rouvinski, A. et al. Nat. Commun. 8, 15411 (2017).
Liu, J. et al. Science 353, 1045–1049 (2016).
Barouch, D. H. et al. Nature 503, 224–228 (2013).
Acknowledgements
We thank V. Cao-Lormeau (Unit of Emerging Infectious Diseases, Institut Louis Malardé; provided Zika virus strain PF-13), E. Moseley, K. McMahan, M. Boyd, M. Kirilova, O. Nanayakkara, Z. Li, N. Mercado, A. Badamchi-Zadeh, M. Iampietro, C. Bricault, P. Gandhi, S. Khatiwada, S. Mojta, B. Alimonti, A. Chandrashekar, A. Brinkman, M. Ferguson, and W. Rinaldi for generous advice, assistance, and reagents. We acknowledge support from the US National Institutes of Health (AI124377, AI126603, AI128751, AI129797) (D.H.B.), the National Institute for Health Research Biomedical Research Centre funding scheme UK (G.R.S), MRC-Newton UK (J.M.), and the Ragon Institute of MGH, MIT, and Harvard (D.H.B.). G.R.S. is a Wellcome Trust Senior Investigator.
Author information
Authors and Affiliations
Contributions
D.H.B. and G.R.S. designed the studies. W.D., P.S., and J.M. produced and characterized the B10 antibody. R.A.L. conducted the mouse studies. P.A. and R.P. conducted the virologic assays. J.P.N. and E.N.B. conducted the monkey study and immunologic assays. D.H.B. wrote the paper with all coauthors.
Corresponding authors
Ethics declarations
Competing interests
The B10 antibody is the subject of patents held by Imperial College and Institute Pasteur on which G.R.S., W.D., and J.M. are inventors.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Figures
Supplementary Figures 1–5
Rights and permissions
About this article
Cite this article
Abbink, P., Larocca, R.A., Dejnirattisai, W. et al. Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys. Nat Med 24, 721–723 (2018). https://doi.org/10.1038/s41591-018-0056-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-018-0056-0
This article is cited by
-
The continued threat of emerging flaviviruses
Nature Microbiology (2020)
-
Maternal vaccination and protective immunity against Zika virus vertical transmission
Nature Communications (2019)
-
A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection
Nature Immunology (2019)
-
The immune response against flaviviruses
Nature Immunology (2018)
-
The emergence of Zika virus and its new clinical syndromes
Nature (2018)